{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:59:14Z","timestamp":1790801954768,"version":"4.1.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["R03AA022479"],"award-info":[{"award-number":["R03AA022479"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES10563"],"award-info":[{"award-number":["R01ES10563"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES07331"],"award-info":[{"award-number":["R01ES07331"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12640-021-00375-5","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T08:03:17Z","timestamp":1621324997000},"page":"1381-1390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Novel Pharmacotherapies in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1703-1842","authenticated-orcid":false,"given":"Yousef","family":"Tizabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruk","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"2","key":"375_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/j.pbj.0000000000000059","volume":"5","author":"C Almeida","year":"2020","unstructured":"Almeida C, Oliveira R, Soares R, Barata P (2020) Influence of gut microbiota dysbiosis on brain function: a systematic review. Porto Biomed j 5(2):1\u20138","journal-title":"Porto Biomed j"},{"issue":"2","key":"375_CR2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/JLB.3A1218-476RR","volume":"106","author":"HR Alrafas","year":"2019","unstructured":"Alrafas HR, Busbee PB, Nagarkatti M (2019) Nagarkatti PS Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells. J Leukoc Biol 106(2):467\u2013480","journal-title":"J Leukoc Biol"},{"issue":"20","key":"375_CR3","first-page":"31641","volume":"S0891\u20135849","author":"CC Anderson","year":"2020","unstructured":"Anderson CC, Marentette JO, Rauniyar AK, Prutton K, Khatri M, Matheson C et al (2020) Maneb alters central carbon metabolism and thiol redox status in a toxicant model of Parkinson\u2019s disease. Free Radic Biol Med S0891\u20135849(20):31641\u201331645","journal-title":"Free Radic Biol Med"},{"key":"375_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-60189-2_12","volume":"18","author":"VM Andrade","year":"2017","unstructured":"Andrade VM, Aschner M (2017) Marreilha Dos Santos AP. Neurotoxicity of Metal Mixtures Adv Neurobiol 18:227\u2013265","journal-title":"Neurotoxicity of Metal Mixtures Adv Neurobiol"},{"key":"375_CR5","first-page":"567","volume":"54","author":"L Antkiewicz-Michaluk","year":"2002","unstructured":"Antkiewicz-Michaluk L (2002) Endogenous risk factors in Parkinson\u2019s disease: dopamine and tetrahydroisoquinolines. Pol J Pharmcol 54:567\u2013572","journal-title":"Pol J Pharmcol"},{"issue":"Suppl 1","key":"375_CR6","first-page":"S148","volume":"10","author":"T Aosaki","year":"2010","unstructured":"Aosaki T, Miura M, Suzuki T, Nishimura K, Masuda M (2010) Acetylcholine-dopamine balance hypothesis in the striatum: an update. Geriatr Gerontol Int 10(Suppl 1):S148\u2013S157","journal-title":"Geriatr Gerontol Int"},{"issue":"4","key":"375_CR7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s13311-020-00889-4","volume":"17","author":"SD Aradi","year":"2020","unstructured":"Aradi SD, Hauser RA (2020) Medical management and prevention of motor complications in Parkinson\u2019s disease. Neurotherapeutics 17(4):1339\u20131365","journal-title":"Neurotherapeutics"},{"key":"375_CR8","doi-asserted-by":"crossref","unstructured":"Assous M (2021) Striatal cholinergic transmission. Focus on nicotinic receptors' influence in striatal circuits. Eur J Neurosci. 53(8):2421\u20132442","DOI":"10.1111\/ejn.15135"},{"issue":"4","key":"375_CR9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00213-019-05430-w","volume":"237","author":"M Azimi","year":"2020","unstructured":"Azimi M, Oemisch M, Womelsdorf T (2020) Dissociation of nicotinic \u03b17 and \u03b14\/\u03b22 sub-receptor agonists for enhancing learning and attentional filtering in nonhuman primates. Psychopharmacology 237(4):997\u20131010","journal-title":"Psychopharmacology"},{"key":"375_CR10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/1570159X15666170818102108","volume":"16","author":"D Bagdas","year":"2018","unstructured":"Bagdas D, Gurun MS, Flood P, Papke RL, Damaj MI (2018) New insights on neuronal nicotinic acetylcholine receptors as targets for pain and inflammation: a focus on \u03b17 nAChRs. Curr Neuropharmacol 16:415\u2013425","journal-title":"Curr Neuropharmacol"},{"key":"375_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2020.02.030","volume":"432","author":"JF Baizabal-Carvallo","year":"2020","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M (2020) The link between gut dysbiosis and neuroinflammation in Parkinson\u2019s disease. Neuroscience 432:160\u2013173","journal-title":"Neuroscience"},{"key":"375_CR12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fnagi.2014.00340","volume":"6","author":"GE Barreto","year":"2015","unstructured":"Barreto GE, Iarkov A, Moran VE (2015) Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson\u2019s disease. Front Aging Neurosci 6:340","journal-title":"Front Aging Neurosci"},{"key":"375_CR13","doi-asserted-by":"crossref","unstructured":"Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM (2019) Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. mBio. 10(1):e02566\u201318","DOI":"10.1128\/mBio.02566-18"},{"issue":"12","key":"375_CR14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3(12):1301\u20131306","journal-title":"Nat Neurosci"},{"key":"375_CR15","first-page":"105065","volume":"161","author":"G Bj\u00f8rklund","year":"2020","unstructured":"Bj\u00f8rklund G, Dadar M, Anderson G, Chirumbolo S, Maes M (2020) Preventive treatments to slow substantia nigra damage and parkinson\u2019s disease progression: a critical perspective. Review Pharmacol Res 161:105065","journal-title":"Preventive Treatments to Slow Substantia Nigra Damage and Parkinson's Disease Progression: A Critical Perspective Review Pharmacol Res"},{"key":"375_CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S (2014) Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat 8:155","journal-title":"Front Neuroanat"},{"issue":"3","key":"375_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/mol.115.102301","volume":"89","author":"D Bolognini","year":"2016","unstructured":"Bolognini D, Tobin AB, Milligan G, Moss CE (2016) The pharmacology and function of receptors for short-chain fatty acids. Mol Pharmacol 89(3):388\u2013398","journal-title":"Mol Pharmacol"},{"key":"375_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.expneurol.2014.09.015","volume":"263","author":"T Bordia","year":"2015","unstructured":"Bordia T, McGregor M, Papke RL, Decker MW, McIntosh JM, Quik M (2015) The \u03b17 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions. Exp Neurol 263:277\u2013284","journal-title":"Exp Neurol"},{"issue":"6","key":"375_CR19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/ejn.14048","volume":"49","author":"T Bordia","year":"2019","unstructured":"Bordia T, Perez XA (2019) Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias. Eur J Neurosci 49(6):859\u2013868","journal-title":"Eur J Neurosci"},{"key":"375_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fneur.2019.00663","volume":"10","author":"TM Cantu-Jungles","year":"2019","unstructured":"Cantu-Jungles TM, Rasmussen HE, Hamaker BR (2019) Potential of prebiotic butyrogenic fibers in Parkinson\u2019s disease. Front Neurol 10:663","journal-title":"Front Neurol"},{"issue":"10","key":"375_CR21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.15698\/mic2019.10.693","volume":"6","author":"G Caspani","year":"2019","unstructured":"Caspani G, Kennedy S, Foster JA, Swann J (2019) Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microb Cell 6(10):454\u2013481","journal-title":"Microb Cell"},{"issue":"1749","key":"375_CR22","doi-asserted-by":"crossref","first-page":"20170174","DOI":"10.1098\/rstb.2017.0174","volume":"373","author":"JP Changeux","year":"2018","unstructured":"Changeux JP (2018) The nicotinic acetylcholine receptor: a typical \u201callosteric machine.\u201d Philos Trans R Soc Lond B Biol Sci 373(1749):20170174","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"12","key":"375_CR23","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1021\/acs.chemrestox.7b00162","volume":"30","author":"L Chi","year":"2017","unstructured":"Chi L, Mahbub R, Gao B, Bian X, Tu P, Ru H et al (2017) Nicotine alters the gut microbiome and metabolites of gut-brain interactions in a sex-specific manner. Chem Res Toxicol 30(12):2110\u20132119","journal-title":"Chem Res Toxicol"},{"issue":"7","key":"375_CR24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS, Yu AC, Golz E, Sundvick K, Kliger D, Radisavljevic N et al (2020) Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov Disord 35(7):1208\u20131217","journal-title":"Mov Disord"},{"issue":"2","key":"375_CR25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(85)90456-1","volume":"348","author":"PB Clarke","year":"1985","unstructured":"Clarke PB, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348(2):355\u2013358","journal-title":"Brain Res"},{"key":"375_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neubiorev.2020.04.018","volume":"115","author":"AA Conti","year":"2020","unstructured":"Conti AA, Tolomeo S, Steele JD, Baldacchino AM (2020) Severity of negative mood and anxiety symptoms occurring during acute abstinence from tobacco: a systematic review and meta-analysis. Neurosci Biobehav Rev 115:48\u201363","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"375_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF03033901","volume":"12","author":"RL Copeland Jr","year":"2007","unstructured":"Copeland RL Jr, Das JR, Kanaan YM, Taylor RE, Tizabi Y (2007) Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res 12(1):61\u201369","journal-title":"Neurotox Res"},{"issue":"10","key":"375_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1176\/appi.ajp.2020.20081182","volume":"177","author":"JS Cruz-Pereira","year":"2020","unstructured":"Cruz-Pereira JS, Cryan JF (2020) In need of a quorum: from microbes to mood via the immune system. Am J Psychiatry 177(10):895\u2013897. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20081182","journal-title":"Am J Psychiatry"},{"issue":"2","key":"375_CR29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF, O\u2019Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179\u2013194","journal-title":"Lancet Neurol"},{"key":"375_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.irn.2015.07.001","volume":"124","author":"JA Dani","year":"2015","unstructured":"Dani JA (2015) Neuronal nicotinic acetylcholine receptor structure and function and response to nicotine. Int Rev Neurobiol 124:3\u201319","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"375_CR31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/wps.20726","volume":"19","author":"TG Dinan","year":"2020","unstructured":"Dinan TG, Cryan JF (2020) Gut microbiota: a missing link in psychiatry. World Psychiatry 19(1):111\u2013112","journal-title":"World Psychiatry"},{"issue":"1","key":"375_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40035-020-00223-0","volume":"9","author":"E Dinter","year":"2020","unstructured":"Dinter E, Saridaki T, Diederichs L, Reichmann H, Falkenburger BH (2020) Parkinson\u2019s disease and translational research. Transl Neurodegener 9(1):43","journal-title":"Transl Neurodegener"},{"key":"375_CR33","doi-asserted-by":"crossref","first-page":"557647","DOI":"10.3389\/fnmol.2020.557647","volume":"13","author":"Y Dong","year":"2020","unstructured":"Dong Y, Bi W, Zheng K, Zhu E, Wang S, Xiong Y et al (2020) Nicotine prevents oxidative stress-induced hippocampal neuronal injury through \u03b17-nAChR\/Erk1\/2 signaling pathway. Front Mol Neurosci 13:557647","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"375_CR34","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","volume":"16","author":"J Dorszewska","year":"2021","unstructured":"Dorszewska J, Kowalska M, Prendecki M, Piekut T, Kozlowska J, Kozubski W (2021) Oxidative stress factors in Parkinson\u2019s disease. Neural Regen Res 16(7):1383\u20131391","journal-title":"Neural Regen Res"},{"key":"375_CR35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.irn.2015.07.002","volume":"124","author":"RE Featherstone","year":"2015","unstructured":"Featherstone RE, Siegel SJ (2015) The Role of Nicotine in Schizophrenia. Int Rev Neurobiol 124:23\u201378","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"375_CR36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","volume":"237","author":"A Fujita","year":"2020","unstructured":"Fujita A, Fujita Y, Pu Y, Chang L, Hashimoto K (2020) MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling. Psychopharmacology 237(1):83\u201392","journal-title":"Psychopharmacology"},{"key":"375_CR37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2018.07.043","volume":"834","author":"M Funakohi-Tago","year":"2018","unstructured":"Funakohi-Tago M, Sakata T, Fujiwara S, Sakakura A, Sugai T, Tago K et al (2018) Hydroxytyrosol butyrate inhibits 6-OHDA-induced apoptosis through activation of the Nrf2\/HO-1 axis in SH-SY5Y cells. Eur J Pharmacol 834:246\u2013256","journal-title":"Eur J Pharmacol"},{"key":"375_CR38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neubiorev.2017.08.018","volume":"84","author":"JA Gandelman","year":"2018","unstructured":"Gandelman JA, Newhouse P, Taylor WD (2018) Nicotine and networks: potential for enhancement of mood and cognition in late-life depression. Neurosci Biobehav Rev 84:289\u2013298","journal-title":"Neurosci Biobehav Rev"},{"key":"375_CR39","doi-asserted-by":"crossref","unstructured":"Ganz\u00a0AB, Beker\u00a0N, Hulsman M, Sikkes S, Netherlands Brain Bank Scheltens P, Smit AB et al (2018) Neuropathology and cognitive performance in self-reported cognitively healthy centenarians. Acta Neuropathol Commun 6(1):64","DOI":"10.1186\/s40478-018-0558-5"},{"issue":"10","key":"375_CR40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41419-020-03063-y","volume":"11","author":"I Genovese","year":"2020","unstructured":"Genovese I, Giamogante F, Barazzuol L, Battista T, Fiorillo A, Vicario M et al (2020) Sorcin is an early marker of neurodegeneration, Ca2+dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases. Cell Death Dis 11(10):861","journal-title":"Cell Death Dis"},{"key":"375_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2018.12.003","volume":"124","author":"B Getachew","year":"2019","unstructured":"Getachew B, Csoka AB, Aschner M, Tizabi Y (2019a) Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: implication for Parkinson\u2019s disease. Neurochem Int 124:19\u201324","journal-title":"Neurochem Int"},{"issue":"1","key":"375_CR42","first-page":"134","volume":"3","author":"B Getachew","year":"2019","unstructured":"Getachew B, Reyes RE, Davies DL, Tizabi Y (2019b) Moxidectin effects on gut microbiota of Wistar-Kyoto rats: relevance to depressive-like behavior. Clin Pharmacol Transl Med 3(1):134\u2013142","journal-title":"Clin Pharmacol Transl Med"},{"key":"375_CR43","doi-asserted-by":"crossref","first-page":"112220","DOI":"10.1016\/j.bbr.2019.112220","volume":"376","author":"B Getachew","year":"2019","unstructured":"Getachew B, Tizabi Y (2019) Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression. Behav Brain Res 376:112220","journal-title":"Behav Brain Res"},{"issue":"3","key":"375_CR44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12640-020-00238-5","volume":"38","author":"B Getachew","year":"2020","unstructured":"Getachew B, Csoka AB, Bhatti A, Copeland RL, Tizabi Y (2020) Butyrate protects against salsolinol-induced toxicity in SH-SY5Y cells: implication for Parkinson\u2019s disease. Neurotox Res 38(3):596\u2013602","journal-title":"Neurotox Res"},{"issue":"4","key":"375_CR45","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2011-06-362434","volume":"119","author":"SK Ghosh","year":"2012","unstructured":"Ghosh SK, Perrine SP, Williams RM, Faller DV (2012) Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood 119(4):1008\u20131017","journal-title":"Blood"},{"issue":"2","key":"375_CR46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/biomedicines9020149","volume":"9","author":"C Giorgi","year":"2021","unstructured":"Giorgi C, Bouhamida E, Danese A, Previati M, Pinton P, Patergnani S (2021) relevance of autophagy and mitophagy dynamics and markers in neurodegenerative diseases. Biomedicines 9(2):149","journal-title":"Biomedicines"},{"key":"375_CR47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.11.020","volume":"70","author":"D Gr\u00fcn","year":"2020","unstructured":"Gr\u00fcn D, Zimmer VC, Kauffmann J, Spiegel J, Dillmann U, Schwiertz A et al (2020) Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson\u2019s disease. Parkinsonism Relat Disord 70:20\u201322","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"375_CR48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2009.04.008","volume":"57","author":"BB Gundersen","year":"2009","unstructured":"Gundersen BB, Blendy JA (2009) Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 57(1):67\u201374","journal-title":"Neuropharmacology"},{"issue":"2","key":"375_CR49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-020-05711-9","volume":"238","author":"B Hahn","year":"2020","unstructured":"Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Ross TJ, Stein EA (2020) Nicotinic receptor modulation of the default mode network. Psychopharmacology 238(2):589\u2013597","journal-title":"Psychopharmacology"},{"key":"375_CR50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.puhe.2019.09.020","volume":"179","author":"C Han","year":"2020","unstructured":"Han C, Lu Y, Cheng H, Wang C, Chan P (2020a) The impact of long-term exposure to ambient air pollution and second-hand smoke on the onset of Parkinson disease: a review and meta-analysis. Public Health 179:100\u2013110","journal-title":"Public Health"},{"issue":"6","key":"375_CR51","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ntr\/ntz126","volume":"22","author":"T Han","year":"2020","unstructured":"Han T, Wang Q, Lai R, Zhang D, Diao Y, Yin Y (2020b) Nicotine induced neurocognitive protection and anti-inflammation effect by activating \u03b1 4\u03b2 2 nicotinic acetylcholine receptors in ischemic rats. Nicotine Tob Res 22(6):919\u2013924","journal-title":"Nicotine Tob Res"},{"key":"375_CR52","doi-asserted-by":"crossref","unstructured":"Harms AS, Ferreira SA, Romero-Ramos M (2021) Periphery and brain, innate and adaptive immunity in Parkinson's disease. Acta Neuropathol. Epub ahead of print","DOI":"10.1007\/s00401-021-02268-5"},{"issue":"3","key":"375_CR53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","volume":"52","author":"MA Hern\u00e1n","year":"2002","unstructured":"Hern\u00e1n MA, Takkouche B, Caama\u00f1o-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease. Ann Neurol 52(3):276\u2013284","journal-title":"Ann Neurol"},{"key":"375_CR54","doi-asserted-by":"crossref","unstructured":"Hou Y, Li X, Liu C, Zhang M, Zhang X, Ge S, Zhao L (2021)\u00a0Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease. Exp Gerontol 111376","DOI":"10.1016\/j.exger.2021.111376"},{"issue":"21","key":"375_CR55","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.18632\/aging.102433","volume":"11","author":"C Huang","year":"2019","unstructured":"Huang C, Ma W, Luo Q, Shi L, Xia Y, Lao C et al (2019) Iron overload resulting from the chronic oral administration of ferric citrate induces parkinsonism phenotypes in middle-aged mice. Aging (albany NY) 11(21):9846\u20139861","journal-title":"Aging (albany NY)"},{"issue":"2","key":"375_CR56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/mol.114.093294","volume":"86","author":"BD Hudson","year":"2014","unstructured":"Hudson BD, Christiansen E, Murdoch H, Jenkins L, Hansen AH, Madsen O et al (2014) Complex pharmacology of novel allosteric free fatty acid 3 receptor ligands. Mol Pharmacol 86(2):200\u2013210","journal-title":"Mol Pharmacol"},{"issue":"2","key":"375_CR57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12640-012-9348-1","volume":"23","author":"LL Hurley","year":"2013","unstructured":"Hurley LL, Tizabi Y (2013) Neuroinflammation, neurodegeneration, and depression. Neurotox Res 23(2):131\u2013144","journal-title":"Neurotox Res"},{"key":"375_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fneur.2020.00395","volume":"11","author":"E Hustad","year":"2020","unstructured":"Hustad E, Aasly JO (2020) Clinical and imaging markers of prodromal Parkinson\u2019s disease. Front Neurol 11:395. https:\/\/doi.org\/10.3389\/fneur.2020.00395","journal-title":"Front Neurol"},{"key":"375_CR59","doi-asserted-by":"crossref","first-page":"567129","DOI":"10.3389\/fnins.2020.567129","volume":"14","author":"A Indrieri","year":"2020","unstructured":"Indrieri A, Pizzarelli R, Franco B, De Leonibus E (2020) Dopamine, alpha-synuclein, and mitochondrial dysfunctions in parkinsonian eyes. Front Neurosci 14:567129","journal-title":"Front Neurosci"},{"key":"375_CR60","doi-asserted-by":"crossref","first-page":"135344","DOI":"10.1016\/j.neulet.2020.135344","volume":"738","author":"I Ivleva","year":"2020","unstructured":"Ivleva I, Pestereva N, Zubov A, Karpenko M (2020) Intranasal exposure of manganese induces neuroinflammation and disrupts dopamine metabolism in the striatum and hippocampus. Neurosci Lett 738:135344","journal-title":"Neurosci Lett"},{"issue":"1","key":"375_CR61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nmo.13157","volume":"30","author":"I Kaji","year":"2018","unstructured":"Kaji I, Akiba Y, Furuyama T, Adelson DW, Iwamoto K et al (2018) Free fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon. Neurogastroenterol Motil 30(1):10","journal-title":"Neurogastroenterol Motil"},{"key":"375_CR62","doi-asserted-by":"crossref","unstructured":"Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Lazaridis K et al (2007) Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.\u00a0FEBS J 274(15):3799\u20133845","DOI":"10.1111\/j.1742-4658.2007.05935.x"},{"issue":"20","key":"375_CR63","first-page":"30086","volume":"S0920\u20139964","author":"JR Kelly","year":"2020","unstructured":"Kelly JR, Minuto C, Cryan JF, Clarke G, Dinan TG (2020) The role of the gut microbiome in the development of schizophrenia. Schizophr Res S0920\u20139964(20):30086\u201330094","journal-title":"Schizophr Res"},{"key":"375_CR64","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB et al (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30:1351\u20131360","journal-title":"Mov Disord"},{"issue":"1","key":"375_CR65","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(1):a008888","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"20","key":"375_CR66","first-page":"30125","volume":"S0166\u20132236","author":"F Koukouli","year":"2020","unstructured":"Koukouli F, Changeux JP (2020) Do nicotinic receptors modulate high-order cognitive processing? Trends Neurosci S0166\u20132236(20):30125\u201330129","journal-title":"Trends Neurosci"},{"key":"375_CR67","unstructured":"Kouli A, Torsney K M, Kuan WL (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications, Chapter 1"},{"key":"375_CR68","doi-asserted-by":"crossref","first-page":"113159","DOI":"10.1016\/j.expneurol.2019.113159","volume":"325","author":"DN Koutzoumis","year":"2020","unstructured":"Koutzoumis DN, Vergara M, Pino J, Buddendorff J, Khoshbouei H, Mandel RJ et al (2020) Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson\u2019s disease. Exp Neurol 325:113159","journal-title":"Exp Neurol"},{"issue":"4587","key":"375_CR69","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"9680","key":"375_CR71","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373(9680):2055\u20132066","journal-title":"Lancet"},{"key":"375_CR72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0278-5846(03)00172-6","volume":"28","author":"S Lemay","year":"2004","unstructured":"Lemay S, Chouinard S, Blanchet P, Masson H, Soland V, Beuter A et al (2004) Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson\u2019s disease. Prog Neuropsychopharm Biol Psychiatry 28:31\u201339","journal-title":"Prog Neuropsychopharm Biol Psychiatry"},{"issue":"9","key":"375_CR73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.tips.2020.06.010","volume":"41","author":"X Li","year":"2020","unstructured":"Li X, Shen L, Hua T, Liu ZJ (2020a) Structural and functional insights into cannabinoid receptors. Trends Pharmacol Sci 41(9):665\u2013677","journal-title":"Trends Pharmacol Sci"},{"key":"375_CR74","doi-asserted-by":"crossref","first-page":"101254","DOI":"10.1016\/j.pmedr.2020.101254","volume":"20","author":"D Li","year":"2020","unstructured":"Li D, Croft DP, Ossip DJ, Xie Z (2020b) The association between statewide vaping prevalence and COVID-19. Prev Med Rep 20:101254","journal-title":"Prev Med Rep"},{"issue":"3","key":"375_CR75","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","volume":"61","author":"X Li","year":"2015","unstructured":"Li X, Li W, Liu G, Shen X, Tang Y (2015) Association between cigarette smoking and Parkinson\u2019s disease: a meta-analysis. Arch Gerontol Geriatr 61(3):510\u2013516","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"375_CR76","first-page":"e5329","volume":"11","author":"A Lieberman","year":"2019","unstructured":"Lieberman A, Deep A, Olson MC, Smith Hussain V, Frames CW, McCauley M et al (2019) Falls when standing, falls when walking: different mechanisms, different outcomes in Parkinson disease. Cureus 11(8):e5329","journal-title":"Cureus"},{"issue":"4","key":"375_CR77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41401-020-0380-z","volume":"41","author":"C Liu","year":"2020","unstructured":"Liu C (2020) Targeting the cholinergic system in Parkinson\u2019s disease. Acta Pharmacol Sin 41(4):453\u2013463","journal-title":"Acta Pharmacol Sin"},{"key":"375_CR78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","volume":"381","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F, Liu S, Du J, Hu X, Xiong J et al (2017a) Sodium butyrate exerts protective effect against Parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci 381:176\u2013181","journal-title":"J Neurol Sci"},{"issue":"7","key":"375_CR79","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/aje\/kww146","volume":"185","author":"Z Liu","year":"2017","unstructured":"Liu Z, Roosaar A, Ax\u00e9ll T, Ye W (2017b) Tobacco use, oral health, and risk of Parkinson\u2019s disease. Am J Epidemiol 185(7):538\u2013545","journal-title":"Am J Epidemiol"},{"key":"375_CR80","doi-asserted-by":"crossref","unstructured":"Liu W, Wang B, Xiao Y, Wang D, Chen W (2020) Secondhand smoking and neurological disease: a meta-analysis of cohort studies. Rev Environ Health. Epub ahead of print","DOI":"10.1515\/reveh-2020-0053"},{"issue":"10","key":"375_CR81","first-page":"e11226","volume":"12","author":"RM Lungba","year":"2020","unstructured":"Lungba RM, Khan SZA, Ajibawo-Aganbi U, Perez Bastidas MV, Veliginti S, Saleem S et al (2020) The role of the gut microbiota and the immune system in the development of autism. Cureus 12(10):e11226","journal-title":"Cureus"},{"issue":"4","key":"375_CR82","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/ajcn\/nqaa186","volume":"112","author":"C Ma","year":"2020","unstructured":"Ma C, Molsberry S, Li Y, Schwarzschild M, Ascherio A, Gao X (2020) Dietary nicotine intake and risk of Parkinson disease: a prospective study. Am J Clin Nutr 112(4):1080\u20131087","journal-title":"Am J Clin Nutr"},{"key":"375_CR83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments. Transl Neurodegener 6:28","journal-title":"Transl Neurodegener"},{"key":"375_CR84","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.lfs.2003.12.001","volume":"75","author":"W Maruyama","year":"2004","unstructured":"Maruyama W, Yi H, Takahashi T, Shimazu S, Ohde H, Yoneda F et al (2004) Neuroprotective function of R-(\u2212)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(\u2212)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells. Life Sci 75:107\u2013117","journal-title":"Life Sci"},{"issue":"4","key":"375_CR85","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ncl.2020.08.003","volume":"38","author":"S McKnight","year":"2020","unstructured":"McKnight S, Hack N (2020) Toxin-induced parkinsonism. Neurol Clin 38(4):853\u2013865","journal-title":"Neurol Clin"},{"key":"375_CR86","doi-asserted-by":"crossref","unstructured":"Meng L, YuanX,\u00a0Xuebing Cao X, Zhang Z (2019) The gut-brain axis in the pathogenesis of Parkinson\u2019s disease. Brain Sci Adv 5(2):73\u201381","DOI":"10.1177\/2096595820902566"},{"issue":"7","key":"375_CR87","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","volume":"18","author":"A Mirelman","year":"2019","unstructured":"Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL et al (2019) Gait impairments in Parkinson\u2019s disease. Lancet Neurol 18(7):697\u2013708","journal-title":"Lancet Neurol"},{"issue":"14","key":"375_CR88","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.3390\/ijms21144918","volume":"21","author":"S Mitra","year":"2020","unstructured":"Mitra S, Khatri SN, Maulik M, Bult-Ito A, Schulte M (2020) Allosterism of nicotinic acetylcholine receptors: therapeutic potential for neuroinflammation underlying brain trauma and degenerative disorders. Int J Mol Sci 21(14):4918","journal-title":"Int J Mol Sci"},{"key":"375_CR89","first-page":"353","volume":"55","author":"B Mravec","year":"2006","unstructured":"Mravec B (2006) Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments. Physiological Research \/ Academia Scientiarum Bohemoslovaca 55:353\u2013364","journal-title":"Physiological Research \/ Academia Scientiarum Bohemoslovaca"},{"key":"375_CR90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0161-813X(03)00099-8","volume":"25","author":"M Naoi","year":"2004","unstructured":"Naoi M, Maruyama W, Nagy GM (2004) Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology 25:193\u2013204","journal-title":"Neurotoxicology"},{"key":"375_CR91","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fnins.2019.00180","volume":"13","author":"A Ndayisaba","year":"2019","unstructured":"Ndayisaba A, Kaindlstorfer C, Wenning GK (2019) Iron in neurodegeneration - cause or consequence? Front Neurosci 13:180. https:\/\/doi.org\/10.3389\/fnins.2019.00180","journal-title":"Front Neurosci"},{"key":"375_CR92","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neubiorev.2020.02.003","volume":"112","author":"ND Nuzum","year":"2020","unstructured":"Nuzum ND, Loughman A, Szymlek-Gay EA, Hendy A, Teo WP, Macpherson H (2020) Gut microbiota differences between healthy older adults and individuals with Parkinson\u2019s disease: a systematic review. Neurosci Biobehav Rev 112:227\u2013241","journal-title":"Neurosci Biobehav Rev"},{"key":"375_CR93","doi-asserted-by":"crossref","first-page":"113020","DOI":"10.1016\/j.bbr.2020.113020","volume":"399","author":"R O'Connor","year":"2021","unstructured":"O\u2019Connor R, van De Wouw M, Moloney GM, Ventura-Silva AP, O\u2019Riordan K, Golubeva AV et al (2021) Strain differences in behaviour and immunity in aged mice: relevance to autism. Behav Brain Res 399:113020","journal-title":"Behav Brain Res"},{"issue":"10","key":"375_CR94","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/mds.20587","volume":"20","author":"EJ O'Reilly","year":"2005","unstructured":"O\u2019Reilly EJ, McCullough ML, Chao A, Henley SJ, Calle EE, Thun MJ et al (2005) Smokeless tobacco use and the risk of Parkinson\u2019s disease mortality. Mov Disord 20(10):1383\u20131384","journal-title":"Mov Disord"},{"key":"375_CR95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fncel.2020.00058","volume":"14","author":"TM Osborn","year":"2020","unstructured":"Osborn TM, Hallett PJ, Schumacher JM, Isacson O (2020) Advantages and recent developments of autologous cell therapy for Parkinson\u2019s disease patients. Front Cell Neurosci 14:58","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"375_CR96","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Sch\u00fctz AL et al (2017) Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet 26(12):2231\u20132246","journal-title":"Hum Mol Genet"},{"key":"375_CR97","doi-asserted-by":"crossref","first-page":"108021","DOI":"10.1016\/j.neuropharm.2020.108021","volume":"168","author":"RL Papke","year":"2020","unstructured":"Papke RL, Lindstrom JM (2020) Nicotinic acetylcholine receptors: conventional and unconventional ligands and signaling. Neuropharmacology 168:108021","journal-title":"Neuropharmacology"},{"issue":"1","key":"375_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-019-00104-z","volume":"37","author":"I Parra","year":"2020","unstructured":"Parra I, Mart\u00ednez I, Ram\u00edrez-Garc\u00eda G, Tizabi Y, Mendieta L (2020) Differential Effects of LPS and 6-OHDA on microglia\u2019s morphology in rats: implications for inflammatory model of Parkinson\u2019s disease. Neurotox Res 37(1):1\u201311","journal-title":"Neurotox Res"},{"key":"375_CR99","doi-asserted-by":"crossref","first-page":"110404","DOI":"10.1016\/j.biopha.2020.110404","volume":"129","author":"CS Pavia","year":"2020","unstructured":"Pavia CS, Plummer MM (2020) Clinical implications of nicotine as an antimicrobial agent and immune modulator. Biomed Pharmacother 129:110404","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"375_CR100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40360-016-0099-0","volume":"17","author":"TV Peres","year":"2016","unstructured":"Peres TV, Schettinger MR, Chen P, Carvalho F, Avila DS, Bowman AB et al (2016) Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies. BMC Pharmacol Toxicol 17(1):57","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"375_CR101","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11065-015-9303-z","volume":"25","author":"XA Perez","year":"2015","unstructured":"Perez XA (2015) Preclinical evidence for a role of the nicotinic cholinergic system in Parkinson\u2019s disease. Neuropsychol Rev 25(4):371\u2013383","journal-title":"Neuropsychol Rev"},{"key":"375_CR102","doi-asserted-by":"crossref","unstructured":"Prenger MTM, Madray R, Van Hedger K, Anello M, MacDonald PA (2020)\u00a0Social symptoms of Parkinson\u2019s disease. Parkinsons Dis 8846544","DOI":"10.20944\/preprints202007.0604.v1"},{"issue":"9","key":"375_CR103","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","volume":"45","author":"CM Qiao","year":"2020","unstructured":"Qiao CM, Sun MF, Jia XB, Li Y, Zhang BP, Zhao LP et al (2020a) Sodium butyrate exacerbates Parkinson\u2019s disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model. Neurochem Res 45(9):2128\u20132142","journal-title":"Neurochem Res"},{"issue":"1","key":"375_CR104","doi-asserted-by":"crossref","first-page":"111772","DOI":"10.1016\/j.yexcr.2019.111772","volume":"387","author":"CM Qiao","year":"2020","unstructured":"Qiao CM, Sun MF, Jia XB, Shi Y, Zhang BP, Zhou ZL et al (2020b) Sodium butyrate causes \u03b1-synuclein degradation by an Atg5-dependent and PI3K\/Akt\/mTOR-related autophagy pathway. Exp Cell Res 387(1):111772","journal-title":"Exp Cell Res"},{"issue":"9\u201310","key":"375_CR105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000505132","volume":"105","author":"J Qiu","year":"2020","unstructured":"Qiu J, Liu R, Ma Y, Li Y, Chen Z, He H et al (2020) Lipopolysaccharide-induced depression-like behaviors is ameliorated by sodium butyrate via inhibiting neuroinflammation and oxido-nitrosative stress. Pharmacology 105(9\u201310):550\u2013560","journal-title":"Pharmacology"},{"issue":"1","key":"375_CR106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12640-013-9433-0","volume":"25","author":"Z Qualls","year":"2014","unstructured":"Qualls Z, Brown D, Ramlochansingh C, Hurley LL, Tizabi Y (2014) Protective effects of curcumin against rotenone and salsolinol induced toxicity: implications for Parkinson\u2019s disease. Neurotox Res 25(1):81\u201389","journal-title":"Neurotox Res"},{"key":"375_CR107","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.irn.2015.07.005","volume":"124","author":"M Quik","year":"2015","unstructured":"Quik M, Bordia T, Zhang D, Perez XA (2015) Nicotine and nicotinic receptor drugs: potential for Parkinson\u2019s disease and drug-induced movement disorders. Int Rev Neurobiol 124:247\u2013271","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"375_CR108","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ntr\/nty063","volume":"21","author":"M Quik","year":"2019","unstructured":"Quik M, Boyd JT, Bordia T, Perez X (2019) Potential therapeutic application for nicotinic receptor drugs in movement disorders. Nicotine Tob Res 21(3):357\u2013369","journal-title":"Nicotine Tob Res"},{"key":"375_CR109","unstructured":"Rani L, Mondal AC (2021) Unravelling the role of gut microbiota in Parkinson\u2019s disease progression: Pathogenic and therapeutic implications. Neurosci Res S0168\u20130102(21):00004\u20133. Epub ahead of print"},{"key":"375_CR110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.10.004","volume":"155","author":"D Reglodi","year":"2017","unstructured":"Reglodi D, Renaud J, Tamas A, Tizabi Y, Soc\u00edas SB, Del-Bel E et al (2017) Novel tactics for neuroprotection in Parkinson\u2019s disease: role of antibiotics, polyphenols and neuropeptides. Prog Neurobiol 155:120\u2013148","journal-title":"Prog Neurobiol"},{"issue":"7","key":"375_CR111","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA et al (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64(7):990\u2013997","journal-title":"Arch Neurol"},{"issue":"32","key":"375_CR112","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.2174\/0929867324666170216113756","volume":"25","author":"R Russo","year":"2018","unstructured":"Russo R, Cristiano C, Avagliano C, De Caro C, La Rana G, Raso GM et al (2018) Gut-brain axis: role of lipids in the regulation of inflammation, pain and CNS diseases. Curr Med Chem 25(32):3930\u20133952","journal-title":"Curr Med Chem"},{"key":"375_CR113","doi-asserted-by":"crossref","first-page":"111245","DOI":"10.1016\/j.fct.2020.111245","volume":"38","author":"JA Ruszkiewicz","year":"2020","unstructured":"Ruszkiewicz JA, Zhang Z, Gon\u00e7alves FM, Tizabi Y, Zelikoff JT, Aschner M (2020) Neurotoxicity of e-cigarettes. Food Chem Toxicol 38:111245","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"375_CR114","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.bjp.0703989","volume":"132","author":"RE Ryan","year":"2001","unstructured":"Ryan RE, Ross SA, Drago J, Loiacono RE (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132(8):1650\u20131656","journal-title":"Br J Pharmacol"},{"issue":"8","key":"375_CR115","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1007\/s10620-017-4600-4","volume":"62","author":"H Said","year":"2017","unstructured":"Said H, Akiba Y, Narimatsu K, Maruta K, Kuri A, Iwamoto KI et al (2017) FFA3 activation stimulates duodenal bicarbonate secretion and prevents NSAID-induced enteropathy via the GLP-2 pathway in rats. Dig Dis Sci 62(8):1944\u20131952","journal-title":"Dig Dis Sci"},{"issue":"12","key":"375_CR116","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.chembiol.2006.09.016","volume":"13","author":"SG Sampathkumar","year":"2006","unstructured":"Sampathkumar SG, Jones MB, Meledeo MA, Campbell CT, Choi SS, Hida K et al (2006) Targeting glycosylation pathways and the cell cycle: sugar-dependent activity of butyrate-carbohydrate cancer prodrugs. Chem Biol 13(12):1265\u20131275","journal-title":"Chem Biol"},{"issue":"1469\u201380","key":"375_CR117","first-page":"e12","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(1469\u201380):e12","journal-title":"Cell"},{"key":"375_CR118","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2017.06.005","volume":"295","author":"M Scarduzio","year":"2017","unstructured":"Scarduzio M, Zimmerman CN, Jaunarajs KL, Wang Q, Standaert DG, McMahon LL (2017) Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia. Exp Neurol 295:162\u2013175","journal-title":"Exp Neurol"},{"key":"375_CR119","doi-asserted-by":"crossref","first-page":"113514","DOI":"10.1016\/j.expneurol.2020.113514","volume":"335","author":"JS Schneider","year":"2021","unstructured":"Schneider JS, Marshall CA, Keibel L, Snyder NW, Hill MP, Brotchie JM et al (2021) A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson\u2019s disease. Exp Neurol 335:113514","journal-title":"Exp Neurol"},{"issue":"4","key":"375_CR120","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/jnnp.2003.010769","volume":"75","author":"J Scholz","year":"2004","unstructured":"Scholz J, Klingemann I, Moser A (2004) Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 75(4):634\u2013636","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"375_CR121","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mds.24012","volume":"27","author":"S Searles Nielsen","year":"2012","unstructured":"Searles Nielsen S, Gallagher LG, Lundin JI, Longstreth WT Jr, Smith-Weller T, Franklin GM et al (2012) Environmental tobacco smoke and Parkinson\u2019s disease. Mov Disord 27(2):293\u2013296","journal-title":"Mov Disord"},{"key":"375_CR122","doi-asserted-by":"crossref","first-page":"107693","DOI":"10.1016\/j.pharmthera.2020.107693","volume":"219","author":"P Seoane-Collazo","year":"2021","unstructured":"Seoane-Collazo P, Di\u00e9guez C, Nogueiras R, Rahmouni K, Fern\u00e1ndez-Real JM, L\u00f3pez M (2021) Nicotine\u2019s actions on energy balance: Friend or foe? Pharmacol Ther 219:107693","journal-title":"Pharmacol Ther"},{"issue":"3","key":"375_CR123","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","volume":"63","author":"S Sharma","year":"2013","unstructured":"Sharma S, Moon CS, Khogali A, Haidous A, Chabenne A, Ojo C et al (2013) Biomarkers in Parkinson\u2019s disease (recent update). Neurochem Int 63(3):201\u2013229","journal-title":"Neurochem Int"},{"issue":"10","key":"375_CR124","doi-asserted-by":"crossref","first-page":"9515","DOI":"10.18632\/aging.103225","volume":"12","author":"L Shi","year":"2020","unstructured":"Shi L, Huang C, Luo Q, Xia Y, Liu W, Zeng W et al (2020) Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson\u2019s disease through AKT\/mTOR pathway. Aging (albany NY) 12(10):9515\u20139533","journal-title":"Aging (albany NY)"},{"key":"375_CR125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fnagi.2019.00215","volume":"11","author":"L Shi","year":"2019","unstructured":"Shi L, Huang C, Luo Q, Rogers E, Xia Y, Liu W et al (2019) The association of iron and the pathologies of Parkinson\u2019s diseases in MPTP\/MPP+-induced neuronal degeneration in non-human primates and in cell culture. Front Aging Neurosci 11:215","journal-title":"Front Aging Neurosci"},{"key":"375_CR126","doi-asserted-by":"crossref","unstructured":"Shimohama S, Kawamata J (2018) Roles of nicotinic acetylcholine receptors in the pathology and treatment of Alzheimer\u2019s and Parkinson\u2019s diseases. 2018 Apr 4 A Akaike S Shimohama Y Misu Eds Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet] Springer Singapore","DOI":"10.1007\/978-981-10-8488-1_8"},{"issue":"6","key":"375_CR127","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/mds.28016","volume":"35","author":"C Shin","year":"2020","unstructured":"Shin C, Lim Y, Lim H, Ahn TB (2020) Plasma short-chain fatty acids in patients with Parkinson\u2019s disease. Mov Disord 35(6):1021\u20131027","journal-title":"Mov Disord"},{"issue":"1","key":"375_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312","journal-title":"Clin Geriatr Med"},{"issue":"9","key":"375_CR129","first-page":"3165","volume":"12","author":"Y Song","year":"2019","unstructured":"Song Y, Wang ZY, Jin YY, Guo J (2019) Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis. Int J Clin Exp Pathol 12(9):3165\u20133170","journal-title":"Int J Clin Exp Pathol"},{"key":"375_CR130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","volume":"69","author":"S Srivastav","year":"2019","unstructured":"Srivastav S, Neupane S, Bhurtel S, Katila N, Maharjan S, Choi H et al (2019) Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J Nutr Biochem 69:73\u201386","journal-title":"J Nutr Biochem"},{"key":"#cr-split#-375_CR131.1","doi-asserted-by":"crossref","unstructured":"St Laurent R, O'Brien LM, Ahmad ST (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease. Neuroscience 246:382-90","DOI":"10.1016\/j.neuroscience.2013.04.037"},{"key":"#cr-split#-375_CR131.2","doi-asserted-by":"crossref","unstructured":"Stoker TB, Barker RA (2020) Recent developments in the treatment of Parkinson's disease.\u00a0F1000Research\u00a09:862","DOI":"10.12688\/f1000research.25634.1"},{"key":"375_CR132","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fnins.2018.00693","volume":"12","author":"TB Stoker","year":"2018","unstructured":"Stoker TB, Torsney KM, Barker RA (2018) Emerging treatment approaches for Parkinson\u2019s disease. Front Neurosci 12:693","journal-title":"Front Neurosci"},{"key":"375_CR133","doi-asserted-by":"crossref","unstructured":"Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology (Berl).\u00a0117(1):2\u201310; discussion 14\u201320","DOI":"10.1007\/BF02245088"},{"key":"375_CR134","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0006-2952(01)00922-4","volume":"63","author":"A Storch","year":"2002","unstructured":"Storch A, Ott S, Hwang YI, Ortmann R, Hein A, Frenzel S et al (2002) Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson\u2019s disease: studies using heterologous expression systems of the dopamine transporter. Biochem Pharmacol 63:909\u2013920","journal-title":"Biochem Pharmacol"},{"key":"375_CR135","doi-asserted-by":"crossref","first-page":"597451","DOI":"10.3389\/fneur.2020.597451","volume":"11","author":"Y Sui","year":"2021","unstructured":"Sui Y, Tian Y, Ko WKD, Wang Z, Jia F, Horn A et al (2021) Deep brain stimulation initiative: toward innovative technology, new disease indications, and approaches to current and future clinical challenges in neuromodulation therapy. Front Neurol 11:597451","journal-title":"Front Neurol"},{"issue":"4","key":"375_CR136","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s13311-020-00924-4","volume":"17","author":"MAC Sy","year":"2020","unstructured":"Sy MAC, Fernandez HH (2020) Pharmacological treatment of early motor manifestations of Parkinson disease (PD). Neurotherapeutics 17(4):1331\u20131338","journal-title":"Neurotherapeutics"},{"key":"375_CR137","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1038\/s41598-019-43502-1","volume":"9","author":"\u00c9 Szentirmai","year":"2019","unstructured":"Szentirmai \u00c9, Millican NS, Massie AR, Kap\u00e1s L (2019) Butyrate, a metabolite of intestinal bacteria, enhances sleep. Sci Rep 9:7035","journal-title":"Sci Rep"},{"issue":"4","key":"375_CR138","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-021-01257-1","volume":"27","author":"Y Tao","year":"2021","unstructured":"Tao Y, Vermilyea SC, Zammit M, Lu J, Olsen M, Metzger JM et al (2021) Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys. Nat Med 27(4):632\u2013639","journal-title":"Nat Med"},{"key":"375_CR139","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/164_2016_52","volume":"236","author":"IG Tikhonova","year":"2017","unstructured":"Tikhonova IG (2017) Application of GPCR structures for modelling of free fatty acid receptors. Handb Exp Pharmacol 236:57\u201377","journal-title":"Handb Exp Pharmacol"},{"key":"375_CR140","doi-asserted-by":"crossref","unstructured":"Terry AV Jr, Callahan PM (2020) \u03b17 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future. Neuropharmacology 170:108053","DOI":"10.1016\/j.neuropharm.2020.108053"},{"issue":"1","key":"375_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-015-9577-1","volume":"30","author":"Y Tizabi","year":"2016","unstructured":"Tizabi Y (2016) Duality of antidepressants and neuroprotectants. Neurotox Res 30(1):1\u201313","journal-title":"Neurotox Res"},{"key":"375_CR142","first-page":"1","volume":"1","author":"Y Tizabi","year":"2017","unstructured":"Tizabi Y, Getachew B (2017) Nicotinic receptor intervention in Parkinson\u2019s disease: future directions. Cin Pharm Transl Med 1:1\u20137","journal-title":"Cin Pharm Transl Med"},{"key":"375_CR143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2019.06.004","volume":"167","author":"Y Tizabi","year":"2019","unstructured":"Tizabi Y, Getachew B, Csoka AB, Manaye KF, Copeland RL (2019) Novel targets for parkinsonism-depression comorbidity. Prog Mol Biol Transl Sci 167:1\u201324","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"17","key":"375_CR144","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1111\/febs.15521","volume":"287","author":"Y Tizabi","year":"2020","unstructured":"Tizabi Y, Getachew B, Copeland RL, Aschner M (2020) Nicotine and the nicotinic cholinergic system in COVID-19. FEBS j 287(17):3656\u20133663","journal-title":"FEBS j"},{"key":"375_CR145","doi-asserted-by":"crossref","unstructured":"Tran J, Anastacio H, Bardy C (2020) Genetic predispositions of Parkinson\u2019s disease revealed in patient-derived brain cells.\u00a0npj Parkinsons Dis. 6:8","DOI":"10.1038\/s41531-020-0110-8"},{"key":"375_CR146","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Unger MM, Spiegel J, Dillmann KU, Grundmann D et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"375_CR147","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1570159X15666171103152136","volume":"16","author":"G Valentine","year":"2018","unstructured":"Valentine G, Sofuoglu M (2018) Cognitive effects of nicotine: recent progress. Curr Neuropharmacol 16(4):403\u2013414","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"375_CR148","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1567202611666140829162158","volume":"11","author":"SS Valvassori","year":"2014","unstructured":"Valvassori SS, Varela RB, Arent CO, Dal-Pont GC, Bobsin TS, Budni J et al (2014) Sodium butyrate functions as an antidepressant and improves cognition with enhanced neurotrophic expression in models of maternal deprivation and chronic mild stress. Curr Neurovasc Res 11(4):359\u2013366","journal-title":"Curr Neurovasc Res"},{"issue":"5","key":"375_CR149","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11764-019-00786-6","volume":"13","author":"JN Vega","year":"2019","unstructured":"Vega JN, Albert KM, Mayer IA, Taylor WD, Newhouse PA (2019) Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study. J Cancer Surviv 13(5):673\u2013686","journal-title":"J Cancer Surviv"},{"key":"375_CR150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4103\/1673-5374.300451","volume":"16","author":"S Vetel","year":"2021","unstructured":"Vetel S, Foucault-Fruchard L, Tronel C, Buron F, Vergote J, Bodard S et al (2021) Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic \u03b17 and \u03c31 receptors in a rat model of Parkinson\u2019s disease. Neural Regen Res 16:1099\u20131104","journal-title":"Neural Regen Res"},{"key":"375_CR151","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/WNL.57.6.1032","volume":"57","author":"A Vieregge","year":"2001","unstructured":"Vieregge A, Sieberer M, Jacobs H, Hagenah JM, Vieregge P (2001) Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study. Neurol 57:1032\u20131035","journal-title":"Neurol"},{"key":"375_CR152","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.3389\/fmicb.2018.03092","volume":"9","author":"DN Villageli\u00fa","year":"2018","unstructured":"Villageli\u00fa DN, Borts DJ, Lyte M (2018) Production of the neurotoxin salsolinol by a gut-associated bacterium and its modulation by alcohol. Front Microbiol 9:3092","journal-title":"Front Microbiol"},{"issue":"10","key":"375_CR153","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2174\/1871527319666200902134129","volume":"19","author":"SM Voon","year":"2020","unstructured":"Voon SM, Ng KY, Chye SM, Ling APK, Voon KGL, Yap YJ et al (2020) The mechanism of action of salsolinol in brain: implications in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 19(10):725\u2013740","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"375_CR154","doi-asserted-by":"publisher","unstructured":"Wills L, Kenny PJ (2021)\u00a0Addiction-related neuroadaptations following chronic nicotine exposure. J Neurochem.\u00a0https:\/\/doi.org\/10.1111\/jnc.15356. Epub ahead of print. PMID: 33742685","DOI":"10.1111\/jnc.15356"},{"issue":"5","key":"375_CR155","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/blood-2002-08-2617","volume":"101","author":"O Witt","year":"2003","unstructured":"Witt O, Monkemeyer S, R\u00f6nndahl G, Erdlenbruch B, Reinhardt D, Kanbach K et al (2003) Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 101(5):2001\u20132007","journal-title":"Blood"},{"key":"375_CR156","doi-asserted-by":"crossref","first-page":"108256","DOI":"10.1016\/j.neuropharm.2020.108256","volume":"177","author":"RE Wittenberg","year":"2020","unstructured":"Wittenberg RE, Wolfman SL, De Biasi M, Dani JA (2020) Nicotinic acetylcholine receptors and nicotine addiction: a brief introduction. Neuropharmacology 177:108256","journal-title":"Neuropharmacology"},{"issue":"1","key":"375_CR157","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJ (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener 12(1):10","journal-title":"Mol Neurodegener"},{"key":"375_CR158","first-page":"872","volume":"46","author":"F Yang","year":"2017","unstructured":"Yang F, Pedersen NL, Ye W, Liu Z, Norberg M, Forsgren L et al (2017) Moist smokeless tobacco (Snus) use and risk of Parkinson\u2019s disease. Int J Epidemiol 46:872\u2013880","journal-title":"Int J Epidemiol"},{"issue":"1","key":"375_CR159","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","volume":"5","author":"CB Yoo","year":"2006","unstructured":"Yoo CB, Jones PA (2006) Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5(1):37\u201350","journal-title":"Nat Rev Drug Discov"},{"key":"375_CR160","doi-asserted-by":"crossref","unstructured":"Zeng XS, Geng WS, Jia JJ, Chen L, Zhang PP (2018) Cellular and molecular basis of neurodegeneration in parkinson disease. Front Aging Neurosci 10:109","DOI":"10.3389\/fnagi.2018.00109"},{"key":"375_CR161","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2018.02.024","volume":"673","author":"X Zheng","year":"2018","unstructured":"Zheng X, Chen X, Guo M, Ali S, Huang Y, Sun F et al (2018) Changes in salsolinol production and salsolinol synthase activity in Parkinson\u2019s disease model. Neurosci Lett 673:39\u201343","journal-title":"Neurosci Lett"},{"key":"375_CR162","doi-asserted-by":"crossref","first-page":"113451","DOI":"10.1016\/j.jep.2020.113451","volume":"266","author":"M Zheng","year":"2021","unstructured":"Zheng M, Chen M, Liu C, Fan Y, Shi D (2021) Alkaloids extracted from Uncaria rhynchophylla demonstrate neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K\/Akt\/mTOR signaling pathway. J Ethnopharmacol 266:113451","journal-title":"J Ethnopharmacol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00375-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-021-00375-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00375-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:09:36Z","timestamp":1744189776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-021-00375-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":162,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["375"],"URL":"https:\/\/doi.org\/10.1007\/s12640-021-00375-5","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}